Faron Pharma details cancer drug's impressive early results in peer-reviewed journal

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF), a specialist in macrophage reprogramming and anticancer immunotherapies, has shared its breakthrough...

Related Keywords

Petri Bono ,Faron Pharmaceuticals Limited ,Cell Reports ,Cell Reports Medicine ,